[The Glivec® case: the first example of a global debate on the drug patent system].

CONCLUSION: The Glivec® case gave rise to an intense debate on the appropriateness of international standards on patents, their applicability and how they should be adopted in each country. This case, as well as other cases, should serve to stimulate reflection on the international patent system and to achieve scenarios in which the health of the poorest populations is protected but also balanced against intellectual property protection and innovation. PMID: 25110309 [PubMed - in process]
Source: Gaceta Sanitaria - Category: Global & Universal Tags: Gac Sanit Source Type: research